Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04855136
Title Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma (KarMMa-7)
Acronym KarMMa-7
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Local Institution - 117 Birmingham Alabama 10016 United States Details
Local Institution - 113 San Francisco California 94143 United States Details
Local Institution - 101 Jacksonville Florida 32224-1865 United States Details
Local Institution - 104 Atlanta Georgia 30322 United States Details
Local Institution - 120 Atlanta Georgia 30342 United States Details
Local Institution - 114 Chicago Illinois 60611 United States Details
Local Institution - 108 Boston Massachusetts 02117 United States Details
Local Institution - 124 Boston Massachusetts 02215 United States Details
Local Institution - 109 Hackensack New Jersey 07601 United States Details
New York University Langone New York New York 10016 United States Details
Local Institution - 110 New York New York 10032 United States Details
Local Institution - 111 Charlotte North Carolina 28204 United States Details
Local Institution - 118 Philadelphia Pennsylvania 19107 United States Details
Local Institution - 103 Nashville Tennessee 37203 United States Details
Local Institution - 107 Houston Texas 77030 United States Details
Local Institution - 201 Pamplona 31008 Spain Details
Local Institution - 202 Salamanca 37007 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field